Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial

The increased prevalence of atrial fibrillation (AF) and heart failure (HF) highlights the need to better understand the mechanisms underlying these cardiovascular diseases (CVDs). In the present study, we aimed to evaluate the association between glycolysis-related metabolites and the risk of AF an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Metabolites
Autori principali: Becerra-Tomás, Nerea, Ruiz-Canela, Miguel, Hernández-Alonso, Pablo, Bulló, Mònica, Li, Jun, Guasch-Ferré, Marta, Toledo, Estefanía, Clish, Clary B., Estruch, Ramon, Ros, Emilio, Fitó, Montserrat, Lee, Chih-Hao, Pierce, Kerry, Arós, Fernando, Serra-Majem, Lluís, Liang, Liming, Razquin, Cristina, Gómez-Gracia, Enrique, Martínez-González, Miguel A., Hu, Frank B., Corella, Dolores, Salas-Salvadó, Jordi
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Brief Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151758/
https://ncbi.nlm.nih.gov/pubmed/34064960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo11050306
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi